Prevention of abnormal scarring in woundhealing
S100 proteins (i.e. Psoriasin, Koebnerisin) for the prevention
of abnormal scarring by reduction of excessive collagen and extracellular matrix production early after wounding.
Further Information: PDF
Bayerische Patentallianz GmbH
Phone: +49 89 5480177-0
Contact
Peer Biskup
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Unidirectional imaging technology breakthrough
UCLA researchers developed unidirectional imaging technology, a crucial capability for applications requiring asymmetric visual information processing and optical communication. Traditional imaging systems are bidirectional—if I can see you, you can…
Implantable microparticles can deliver two cancer therapies at once
The combination of phototherapy and chemotherapy could offer a more effective way to fight aggressive tumors. Patients with late-stage cancer often have to endure multiple rounds of different types of…
Researchers Aim To Get Leg Up on Bone Repair with 3D-Printed Femur
University of Texas at Dallas mechanical engineers have designed a 3D-printed femur that could help doctors prepare for surgeries to repair bones and develop treatments for bone tumors. The engineers,…